Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
558,707
-
Share change
-
+57,257
-
Total reported value
-
$168,069,461
-
Price per share
-
$303.81
-
Number of holders
-
92
-
Value change
-
+$16,578,918
-
Number of buys
-
53
-
Number of sells
-
32
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2025
As of 31 Dec 2025,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
558,707 shares.
The largest 10 holders included
UBS Group AG, JENNISON ASSOCIATES LLC, Mirae Asset Global Investments Co., Ltd., Atle Fund Management AB, ABN AMRO INVESTMENT SOLUTIONS, OPPENHEIMER ASSET MANAGEMENT INC., Slow Capital, Inc., ASSETMARK, INC, Asset Management One Co., Ltd., and DekaBank Deutsche Girozentrale.
This page lists
92
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.